| __timestamp | Amneal Pharmaceuticals, Inc. | Evotec SE |
|---|---|---|
| Wednesday, January 1, 2014 | 106735000 | 12404000 |
| Thursday, January 1, 2015 | 136870000 | 18343000 |
| Friday, January 1, 2016 | 204747000 | 18108000 |
| Sunday, January 1, 2017 | 191938000 | 17614000 |
| Monday, January 1, 2018 | 210451000 | 35619000 |
| Tuesday, January 1, 2019 | 202287000 | 58432000 |
| Wednesday, January 1, 2020 | 190585000 | 63945000 |
| Friday, January 1, 2021 | 209563000 | 72200000 |
| Saturday, January 1, 2022 | 200046000 | 76642000 |
| Sunday, January 1, 2023 | 167778000 | 57519000 |
Unleashing insights
In the competitive world of pharmaceuticals, research and development (R&D) is the lifeblood of innovation. Amneal Pharmaceuticals, Inc. and Evotec SE, two prominent players, have shown distinct strategies in their R&D allocations over the past decade. From 2014 to 2023, Amneal consistently invested more in R&D, peaking in 2018 with a 97% increase from 2014. However, by 2023, their spending saw a 20% decline from its peak. In contrast, Evotec SE's R&D expenses grew steadily, with a remarkable 363% increase from 2014 to 2022, before a slight dip in 2023. This divergence highlights Amneal's fluctuating strategy versus Evotec's consistent growth approach. As the pharmaceutical landscape evolves, these trends offer insights into how each company navigates innovation and market demands.
Comparing Innovation Spending: Eli Lilly and Company and Evotec SE
Who Prioritizes Innovation? R&D Spending Compared for Zoetis Inc. and Evotec SE
Research and Development: Comparing Key Metrics for Grifols, S.A. and Evotec SE
R&D Insights: How Amneal Pharmaceuticals, Inc. and Catalyst Pharmaceuticals, Inc. Allocate Funds
Amneal Pharmaceuticals, Inc. vs Soleno Therapeutics, Inc.: Strategic Focus on R&D Spending
R&D Insights: How Amneal Pharmaceuticals, Inc. and Agios Pharmaceuticals, Inc. Allocate Funds
Research and Development: Comparing Key Metrics for Amneal Pharmaceuticals, Inc. and Supernus Pharmaceuticals, Inc.
Research and Development: Comparing Key Metrics for Amneal Pharmaceuticals, Inc. and MiMedx Group, Inc.
Research and Development Investment: Rhythm Pharmaceuticals, Inc. vs Evotec SE
Comparing Innovation Spending: MorphoSys AG and Evotec SE
Comparing Innovation Spending: Wave Life Sciences Ltd. and Evotec SE
Research and Development Investment: Celldex Therapeutics, Inc. vs Evotec SE